Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGASE07: Docetaxel-5FU Maintenance in Inflammatory Breast Cancer
NCT02324088Phase 3Completed
- Sponsor
- Unicancer
- Start
- Oct 2000
- Primary completion
- Dec 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of docetaxel, fluorouracil in inflammatory breast cancer (IBC), sponsored by Unicancer. Started Oct 2000; status: completed.
02
Drugs
docetaxelfluorouracil
03
Conditions
inflammatory breast cancer (IBC)
Beyond the preview
Go deeper on NCT02324088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324088.